Terms: = Germ cell tumor AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
79 results:
1. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
[TBL] [Abstract] [Full Text] [Related]
2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
3. Radiomic profiling for insular diffuse glioma stratification with distinct biologic pathway activities.
Duan W; Wang Z; Ma Z; Zheng H; Li Y; Pei D; Wang M; Qiu Y; Duan M; Yan D; Ji Y; Cheng J; Liu X; Zhang Z; Yan J
Cancer Sci; 2024 Apr; 115(4):1261-1272. PubMed ID: 38279197
[TBL] [Abstract] [Full Text] [Related]
4. Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
[TBL] [Abstract] [Full Text] [Related]
5. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
6. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
7. GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma.
Qiao X; Chen Y; Wang Z; Peng N; Niu W; Hou S; Wu J; Ji Y; Niu C; Cheng C
Cancer Gene Ther; 2023 Dec; 30(12):1702-1714. PubMed ID: 37845349
[TBL] [Abstract] [Full Text] [Related]
8. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
9. MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
Wu HW; Wu CH; Lin SC; Wu CC; Chen HH; Chen YW; Lee YY; Chang FC
Cancer Med; 2023 May; 12(9):10449-10461. PubMed ID: 36916326
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract] [Full Text] [Related]
11. Radiotherapy and Immunotherapy in Melanoma Brain Metastases.
Anvari A; Sasanpour P; Kheradmardi MR
Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):1-20. PubMed ID: 36634277
[TBL] [Abstract] [Full Text] [Related]
12. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
[TBL] [Abstract] [Full Text] [Related]
13. Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma.
Tang Q; Xu F; Lin J; Zhang C; Liu X; Dong L; Zhao J; Zhu L; Lin T
Exp Eye Res; 2022 Nov; 224():109221. PubMed ID: 36041510
[TBL] [Abstract] [Full Text] [Related]
14. Potential mechanisms underlying the promoting effects of 3D collagen scaffold culture on stemness and drug resistance of glioma cells.
Jia W; Zhu H; Zhao M; Zhou Q; Yin W; Liu W; Wang L; Xiao Z; Jiang X; Dai J; Ren C
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166522. PubMed ID: 35981653
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.
Tan Q; Wang X; Li Y; Liu Y; Liu X; Ke N
Front Endocrinol (Lausanne); 2022; 13():907415. PubMed ID: 35873006
[TBL] [Abstract] [Full Text] [Related]
16.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract] [Full Text] [Related]
17. The RNA-Binding Protein Musashi1 Regulates a Network of cell Cycle Genes in Group 4 Medulloblastoma.
Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
[TBL] [Abstract] [Full Text] [Related]
18. ZC3H15 Correlates with a Poor prognosis and tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract] [Full Text] [Related]
19. NAP1L1 promotes proliferation and chemoresistance in glioma by inducing ccnd1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.
Chen Z; Xie Y; Luo H; Song Y; Que T; Hu R; Huang H; Luo K; Li C; Qin C; Zheng C; Fang W; Liu L; Long H; Luo Q
Aging (Albany NY); 2021 Dec; 13(24):26180-26200. PubMed ID: 34959221
[TBL] [Abstract] [Full Text] [Related]
20. The function and mechanism of the JARID2/ccnd1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ).
Kuang W; Jiang W; Chen Y; Tian Y; Liu Z
Cancer Biol Ther; 2021 Jun; 22(5-6):392-403. PubMed ID: 34251962
[TBL] [Abstract] [Full Text] [Related]
[Next]
